DNA Methylation: A Potential Biomarker of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a serious public health concern worldwide. By 2040, 4.41 million people are estimated to expire annually due to COPD. However, till date, it has remained difficult to alter the activity or progress of the disease through treatment. In order to address...
Main Authors: | Lin-Xi He, Zhao-Hui Tang, Qing-Song Huang, Wei-Hong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00585/full |
Similar Items
-
Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
by: Comes Alexandra, et al.
Published: (2016-06-01) -
DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD
by: Isaac K. Sundar, et al.
Published: (2017-04-01) -
Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers
by: Guzmán Leda, et al.
Published: (2012-07-01) -
A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules
by: Wenqun Xing, et al.
Published: (2021-03-01) -
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
by: Ana I. Hernández Cordero, et al.
Published: (2021-12-01)